Benefit-Risk Appraisal of Medicines

Name: Benefit-Risk Appraisal of Medicines
Brand: John Wiley & Sons Inc
SKU: 2212362
Author: Filip (Johnson Mussen

Filip (Johnson Mussen, Belgium) Johnson Pharmaceuticals, UK) Sam (Cardiff University Salek, UK) Stuart (CMR International Institute for Regulatory Science Walker

John Wiley & Sons Inc

Knihu koupíte v 1 e-shopu

Bookshop.cz

2 789 Kč

Není skladem

Do obchodu

Krátký popis

Establishes the criteria required to assess benefit-risk in general and reviews the current practice of benefit-risk assessment by drug regulatory authorities and the pharmaceutical industry. Outlines how the new MCDA model was developed and evaluated, and discusses the implications of its…

Zobrazit celý popis

Výběr knih vydavatele John Wiley & Sons Inc